Drug List Changes
2012 Aetna Medicare Rx Plan (PDP)
Here are changes from a recent review of Aetna Medicare's Preferred Drug List (formulary). They are based on findings from the Food and Drug Administration (FDA) and drug makers, and other factors including cost. Changes occur, for example, because new drugs come on the market, we may learn that a prescription drug should now have a lower dose, it's moved to a different cost-sharing level (tier), or a generic version becomes available. We change our list to help provide you with appropriate, affordable drug benefits.
Carefully review the monthly changes below and their effective dates. If you are affected by preferred drug list changes, you will receive a letter explaining the changes. You can also speak with your doctor or pharmacist about the preferred drug list changes.
View full Aetna Medicare Rx Plan (PDP) 2012 Comprehensive Formulary - Y0001_M_PE_MM_11125 CMS Approved 11/22/2011 (114 pages, 1,187 kb) - Last Updated 12/27/2012
|UPPERCASE = Brand-name medications||QL = Quantity limits|
|lower case italics = generic medications||ST = Step therapy|
|Tier 1, 2, 3, 4, 5 = Copay tier level||PR = Prior authorization|
Date of Change: October 1, 2011
|Drug Name||Change Type||Alternative||What You Need to Know|
See the Aetna Medicare 2012 Glossary for unfamiliar terms.
See the Aetna Medicare Rx 2012 Find Prescriptions page for more information about Aetna Medicare's preferred drug list (formulary).
If you need to request an exception to the formulary, utilization management, or tiered cost sharing, please visit the Aetna Medicare Rx Plan website section, "Exceptions, Appeals & Grievances" for more information.
Public notice of transition process
The Centers for Medicare and Medicaid Services (CMS) implemented a transition program to allow Medicare Part D members to receive a temporary supply of medication to avoid disruption of medication therapy.
Aetna has established a transition program that provides new and existing members with up to a one time fill (maximum of a 31-day supply OR multiple fills for a combined medication supply of no more than 31 days) for each prescription:
- that you may already be taking and
- that is not on our formulary, or
- that requires prior authorization (precertification), quantity limits, or step therapy.
Review details on our transition process. Y0001_M_OT_WB_10670 CMS Approved 10/04/2011 (4 pages, 50 kb)
(Last updated 12/27/2012)
Formulary ID: 12369, Version 29
You will need Adobe® Acrobat Reader to view some of the materials. You can download the latest Acrobat Reader software free by clicking this link. Download Adobe Reader.